GTX Genetix Grp

RNS Number:5873L
Genetix Group PLC
27 April 2005

                               Genetix Group plc

                        Annual General Meeting Statement

New Milton, UK, 27 April 2005 - The Board of Genetix Group plc (LSE: GTX) ("
Genetix" or the "Company"), a leading provider of intelligent solutions for
systems biology, held its Annual General Meeting today at 11.30am at which all
resolutions were duly passed.



Enquiries:

Genetix Group plc

Mark Reid, Chief Executive

Gary Corsi, Finance Director

Tel:  01425 624600



Financial Dynamics

Julia Phillips/Sarah MacLeod

Tel:  020 7831 3113



The release will be available on the Company's website: www.genetix.com



Notes to Editors



About Genetix Group plc

Genetix provides automated systems for cell biology, and proteomic and genomic
research.  It supplies many leading academic institutions worldwide and major
international companies involved in the drug discovery process including GSK,
AstraZeneca and Novartis.

Through its R&D expertise and scientific resource, Genetix is committed to the
continual development of innovative solutions to accelerate the rate of global
scientific discovery.  The Company made a significant contribution to the Human
Genome Project by supplying high-throughput equipment to seven of the leading
eight laboratories of the consortium.

Genetix is quoted on the London Stock Exchange (symbol GTX) and is based in New
Milton, Hampshire, UK.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGMIRMBTMMITBIA

Genetix Grp (LSE:GTX)
Historical Stock Chart
From Aug 2024 to Sep 2024

Genetix Grp (LSE:GTX)
Historical Stock Chart
From Sep 2023 to Sep 2024